FindTrial
Sign In

Omega-3 fatty acids in prevention of atrial fibrillation after open heart surgery - Omega-3 in postop a. fib.

Omega-3 fatty acids in prevention of atrial fibrillation after open heart surgery - Omega-3 in postop a. fib.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-002226-21-IS
Enrollment
200
Registered
2004-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2012-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation after open heart surgery

Interventions

Product Name: Omega Forte Pharmaceutical Form: Capsule* Pharmaceutical form of the placebo: Capsule* Route of administration of the placebo: Oral use

Sponsors

None listed

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Open heart surgery, including coronary artery bypass and valvular operations Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Age below 50 years of age. History of atrial fibrillaton. Use of amiodarone or sotalol. Acute surgery.

Design outcomes

Primary

MeasureTime frame
Main Objective: To evaluate whether the perioperative administration of omega-3 polyunsaturated fatty acids can prevent the occurrence of atrial fibrillaton following open heart surgery. ;Secondary Objective: ;Primary end point(s): Atrial fibrillation in the period following the open heart surgery until hospital discharge—

Countries

Iceland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026